about
The BRAIN Initiative: developing technology to catalyse neuroscience discovery.Optogenetic dissection of ictal propagation in the hippocampal-entorhinal cortex structures.Optogenetic tools for modulating and probing the epileptic networkChanging channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitabilityEpilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task ForceThe Subiculum: A Potential Site of Ictogenesis in a Neonatal Seizure Model.In vivo expression of a light-activatable potassium channel using unnatural amino acidsSeizure suppression by high frequency optogenetic stimulation using in vitro and in vivo animal models of epilepsyOptogenetic control of human neurons in organotypic brain cultures.A brain slice experimental model to study the generation and the propagation of focally-induced epileptiform activityTools, methods, and applications for optophysiology in neuroscienceHow might novel technologies such as optogenetics lead to better treatments in epilepsy?Different subsets of newborn granule cells: a possible role in epileptogenesis?Optogenetic Approaches for Controlling Seizure Activity.Optogenetic activation of VGLUT2-expressing excitatory neurons blocks epileptic seizure-like activity in the mouse entorhinal cortexMicrobial Proteins as Novel Industrial Biotechnology Hosts to Treat Epilepsy.Dcf1 Improves Behavior Deficit in Drosophila and Mice Caused by Optogenetic Suppression.Molecular mechanism of circadian rhythmicity of seizures in temporal lobe epilepsy.Cocaine-Induced Changes in Low-Dimensional Attractors of Local Field Potentials in Optogenetic Mice.
P2860
Q26849487-49A31FFA-B454-4C33-89F7-CE157604289BQ27324415-EBDC25C7-5150-4A74-8D0F-D0B71D8412B4Q28080896-0E933A78-59FA-4304-B9E1-BEE96EC3C532Q28081164-7BB752A2-17F0-45D7-A0F9-B62A563032AAQ28595920-EADC95E5-CCE6-4E06-81B8-88F52A0B87DFQ33581136-B646CDFF-EA05-4916-8F94-35D419681B26Q34378622-DF619A52-CDE3-46A7-8400-612AA7164D91Q34657035-B6E4693A-8308-4795-9444-39E5F7E11A6CQ35995266-4CB52BA8-9AB7-4E57-BB21-8933D40FFE4CQ36575469-8FA70263-8D86-495C-B74A-8B8A89075445Q37019105-83FE1B4B-FD0E-4DC3-BFC6-7A5F33D61A11Q37142362-028CA711-2ACD-481A-8EB9-F85275DF775AQ38175482-C967ACFF-88F1-4456-9E91-DA8FB675A2D9Q38834011-FC7A3409-5FEF-4E08-AAB6-4D657F221770Q38946614-C5F2D05F-286A-421A-88CE-DE699E85825CQ39025252-DB03B8D1-8CF2-4DD2-B009-E33263AD5838Q40246502-4E06FBE6-2029-4189-9542-1E84AAB36CC2Q42348037-B7A78465-CDC4-44AA-A8E3-632F97F3CC3FQ49328625-9B9B4310-4183-4A61-A5F4-132BB62CF026
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
An optogenetic approach in epilepsy.
@ast
An optogenetic approach in epilepsy.
@en
An optogenetic approach in epilepsy.
@nl
type
label
An optogenetic approach in epilepsy.
@ast
An optogenetic approach in epilepsy.
@en
An optogenetic approach in epilepsy.
@nl
prefLabel
An optogenetic approach in epilepsy.
@ast
An optogenetic approach in epilepsy.
@en
An optogenetic approach in epilepsy.
@nl
P2093
P1433
P1476
An optogenetic approach in epilepsy.
@en
P2093
Marco Ledri
Merab Kokaia
My Andersson
P356
10.1016/J.NEUROPHARM.2012.05.049
P577
2012-06-12T00:00:00Z